Advertisement

Related Videos

Welcome and Introduction to Vi3C

Cody Peer, PhD, on Simulating Alternative Schedules for Checkpoint Inhibitors

Daniel Goldstein, MD: Interventional Pharmacoeconomics - Why and How

The Interventional Pharmacoeconomic Toolbox Panel Discussion

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

Advertisement

Advertisement




Nov
03
Today In Oncology
Researchers Explore Potential Strategy for Overcoming Resistance to RAS Inhibitors
TIL Therapy Plus Pembrolizumab for Advanced Melanoma
High-Risk Melanoma Personalized mRNA Vaccine Plus Immunotherapy Reduces Risk of Recurrence After Surgery
Phase III VOLGA Trial Explores Outcomes in Muscle Invasive Bladder Cancer
Current Public Knowledge Rates on Alcohol and Cancer Risks
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo